The author discusses the misconceptions and controversy of the studies of computed tomography (CT) screening for lung cancer in the U.S. He investigates the study conducted by the National Lung Screening Trial (NLST) which closed with headlines of a significant reduction in lung cancer mortality in the CT arm. He also notes that the NLST has shown that CT screening for lung cancer is a safe and effective means to detect early lung cancer.